Compete or not? : evidence from global biopharmaceutical innovation and market
| Year of publication: |
2024
|
|---|---|
| Authors: | Zhang, Lili ; Guo, Ying ; Zhang, Yi ; Su, Jun |
| Published in: |
International journal of technology management : IJTM. - Geneva : Inderscience Enterprises Ltd, ISSN 1741-5276, ZDB-ID 2048159-7. - Vol. 94.2024, 2, p. 213-241
|
| Subject: | biopharmaceutical | market competition | market size | technological innovation | Innovation | Wettbewerb | Competition | Pharmaindustrie | Pharmaceutical industry | Marktgröße | Market size | Innovationsmanagement | Innovation management | Biotechnologie-Industrie | Biotechnology industry | Technischer Fortschritt | Technological change | Marktstruktur | Market structure | Wettbewerbsstrategie | Competitive strategy | Welt | World |
-
Market size and innovation : effects of Medicare Part D on pharmaceutical research and development
Blume-Kohout, Margaret E., (2013)
-
Downstream competition and upstream innovation : theory and evidence from China
Dai, Jing, (2024)
-
Market Size and Innovation : The Intermediary Role of Technology Licensing
Hermosilla, Manuel, (2018)
- More ...
-
Technology stocks : a study on the characteristics that help transfer public research to industry
Lian, Xiangpeng, (2021)
-
How patent signals affect venture capital : the evidence of bio-pharmaceutical start-ups in China
Zhang, Lili, (2019)
-
Zhang, Lili, (2019)
- More ...